Skip to main content
. 2006 Jul 19;2006(3):CD006148. doi: 10.1002/14651858.CD006148

Verhofstede 1999.

Methods N=9 
 Non randomized 
 FUP=unclear 
 W/o d/o: unreported
Participants Eligibility:‐ 
 NRTI regimen, 
 VL (15,924‐997.361) copies/ml,
Interventions TI unclear duration
Outcomes VL rebound: 77% participants 
 Loss of mutations: 88% participants
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Unclear risk D ‐ Not used